If you listen to the nation’s largest Alzheimer’s ailment advocacy organizations, you may well imagine all people dwelling with Alzheimer’s would like unfettered access to Aduhelm, a controversial new remedy. Views about Aduhelm (also recognized as aducanumab) in the dementia group are various, ranging from “we want the federal government […]